Centene CNC · NYSE
$69.15 -1.93% (-$1.36)
Summary
42 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $24.2B against $16.1B.
- The share price is below the Bulios Fair Price.
- Revenue grew by 10% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 10% a year. For the next fiscal year analysts expect revenue to grow by 0.7%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $5.10B.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.8 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 27
- Hold 16
- Sell 1
Today's price within the analysts' price targets
The average target of $68.29 is 1.2% below today's price. 61% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Medicaid Segment 76%
- Commercial Segment 22%
- Other Operating Segment 2.6%
By region
The company reports no revenue by region.
Medicaid Segment brings in 76% of revenue.
Segments in detail